Paying users zone. Data is covered by .

  • Get to Biogen Inc. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

 

$15.99

Common-Size Income Statement

Difficulty: Beginner

Biogen Inc., Common-Size Consolidated Income Statement

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Product, net                    
Revenues from anti-CD20 therapeutic programs                    
Other                    
Revenues % % % % %
Cost of sales, excluding amortization of acquired intangible assets                    
Gross profit % % % % %
Research and development                    
Selling, general and administrative                    
Amortization of acquired intangible assets                    
Acquired in-process research and development                    
Collaboration profit sharing                    
Gain (loss) on fair value remeasurement of contingent consideration                    
Restructuring charges                    
TECFIDERA litigation settlement charges                    
Gain on sale of rights                    
Income from operations % % % % %
Interest income                    
Interest expense                    
Impairments on investments                    
Gain (loss) on investments, net                    
Foreign exchange gains (losses), net                    
Other, net                    
Other income (expense), net % % % % %
Income before income tax expense and equity in loss of investee, net of tax % % % % %
Income tax expense                    
Equity in loss of investee, net of tax                    
Net income % % % % %
Net (income) loss attributable to noncontrolling interests, net of tax                    
Net income attributable to Biogen Inc. % % % % %

Top